The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant. - Inge M. M. Lakeman, Alexandra J. van den Broek, Juliën A. M. Vos, Antoine de Pauw, Laurence Faivre, Sandra Fert Ferrer, Marion Gauthier-Villars, Paul Gesta, Sophie Giraud, Lisa Golmard, Claude Houdayer, Christine Lasset, Maïté Laurent, Dominique Leroux, Michel Longy - Dissemin

Language
Login

Published in

Elsevier, Genetics in Medicine, 9(23), p. 1726-1737, 2021

DOI: 10.1038/s41436-021-01198-7

Links

Tools

Export citation

Search in Google Scholar

The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.

Journal article published in 2021 by Inge M. M. Lakeman, Alexandra J. van den Broek, Juliën A. M. Vos, Antoine de Pauw, Laurence Faivre, Sandra Fert Ferrer, Marion Gauthier-Villars, Paul Gesta, Sophie Giraud, Lisa Golmard, Claude Houdayer, Christine Lasset, Maïté Laurent, Dominique Leroux, Michel Longy and other authors.

This paper was not found in any repository, but could be made available legally by the author.

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle

Preprint: archiving allowed

Upload

Red circle

Postprint: archiving forbidden

Red circle

Published version: archiving forbidden

Policy details

Data provided by

SHERPA/RoMEO